(ProRx Pharma) - From hospitals to surgical centers, med spas to even your dentist’s office—chances are, you or someone in your family has already received medication from a compounding pharmacy without even knowing it.

But what exactly is a compounding pharmacy? And what makes some compounding pharmacies, known as 503B outsourcing facilities, so critical to modern healthcare?

A Brief Look Back

Compounding pharmacies have been around for centuries—long before mass-produced medications were the norm. In the earliest days of medicine, pharmacists prepared customized remedies by hand, adjusting dosages, ingredients, and formulations to suit individual patients. While much of pharmacy practice shifted to manufactured drugs over the 20th Century, the need for tailored treatments never disappeared.

In 2013, Congress passed the Drug Quality and Security Act (DQSA), creating a new category of compounding pharmacies: 503B outsourcing facilities. These facilities are authorized to compound large batches of medications in advance—often for use in hospitals and physician clinics—and are held to strict quality and sterility standards by the FDA.

Why It Matters to You

503B outsourcing facilities are behind the scenes of much of our healthcare system and the modern wellness journey. While you can’t pick up a prescription directly from one, the preparations they compound are frequently administered during medical procedures, inpatient stays, or outpatient visits.

Some common scenarios include:

· A child in the ER receives a weight-based dose of a pain reliever made by a 503B facility.

· An older adult undergoing eye surgery gets pre-filled syringes of anesthesia prepared in sterile conditions.

· A patient at a wellness clinic receives a compounded vitamin infusion tailored for their specific nutrient needs.

Unlike traditional “503A” compounding pharmacies, which prepare medications based on a specific prescription for one patient, 503B facilities are allowed to produce office-use medications in advance—making them vital to hospitals, ambulatory surgery centers, infusion clinics, med spas, and even long-term care providers. Patients may receive medications prepared by a 503B outsourcing facility, but they do so only through their healthcare provider, since 503Bs are not permitted to serve patients directly.

Safety and Quality Come First

Not all compounding pharmacies are the same. 503B facilities must register with the FDA, follow Current Good Manufacturing Practices (cGMP), and undergo regular inspections. These guidelines are designed to protect patients by ensuring preparations are sterile, precisely dosed, and free of contaminants.

When your healthcare provider suggests using a compounding partner, do your due diligence and ask questions, even visit the compounder’s website. Three questions you should ask:

1. Is the compounding pharmacy accredited by the Pharmacy Compounding Accreditation Board (PCAB) or another recognized organization?

2. Is the pharmacy licensed in my state and do they follow guidelines for compounding?

3. Does the pharmacy regularly test for potency, sterility (if applicable) and contamination?

So the next time you or a loved one gets a procedure, an injection, or a specialty treatment, there’s a good chance a compounding pharmacy was part of the process—quietly working behind the scenes to keep you safe, healthy, and healing.

For more information about compounding pharmacies, visit https://prorxpharma.com.

(NewsUSA) - By Matt Werbach for the National Psoriasis Foundation 

If you are one of the 8 million people in the U.S. with psoriasis, no one needs to tell you about the challenges of living with the disease. You know the pain and itch. You know the social stigma and the judgmental stares. And if you’re like Brian, Ayesha, or Janene, you also carry the burden of various related diseases.  

There are so many shared challenges related to living with psoriasis that it becomes easy to imagine a common solution. But each person impacted by this disease – all 125 million worldwide – has their own unique set of genetics, lifestyle considerations, luck, and personal history. Let’s hear from three of them. 

Three Unique Journeys 

Regaining Control 

Brian Lehrschall spent 30 years managing his psoriasis with just about every treatment available. It was high blood sugar and the GLP-1 agonist he took to manage it that finally helped him improve his psoriasis symptoms, his treatment effectiveness, and his ability to enjoy life. 

Losing it All 

Ayesha Patrick’s hair was falling out in clumps. Psoriasis robbed her of her health, hair, and mental wellbeing. She regained her strength and persevered by helping other people of color feel supported through whatever psoriasis throws their way.  

“Something is Not Right” 

Janene Tirado was pouring margaritas for grateful golfers at a volunteer event when a rare form of psoriasis known as GPP appeared. Within hours, she was at the hospital with a fever, nausea, and small pustules spreading rapidly across her feet and lower legs. Proper treatment helped her move forward. Now, she shares her story so others might know the signs of GPP. 

August is Psoriasis Action Month – an annual opportunity to galvanize and empower the community of people impacted by psoriasis and psoriatic arthritis (PsA). Every person experiences psoriatic disease in their own unique way, but it is together that we drive progress toward the vision of a world free from the burdens of psoriasis and PsA.  

For real stories, practical tips, and helpful tools to live your healthiest life with psoriasis or PsA, visit psoriasis.org/psoriasis-action-month. 

(Amy Leitman, JD, President of NTMir Contributor, USA Today) - For most Americans, the letters "NTM" don’t mean anything. But for tens of thousands of people across the country, they represent something serious: a chronic lung disease that’s often overlooked, misunderstood, and on the rise.

NTM, or nontuberculous mycobacterial lung disease, isn’t contagious. But that doesn’t make it harmless. Caused by bacteria found in soil and water, NTM can lead to progressive lung damage, especially in people with underlying respiratory conditions. What’s most alarming is how easily it hides in plain sight—mimicking other illnesses, evading detection, and often going untreated for years.

As we approach World NTM Day on August 4, it’s time to bring this disease out of the shadows.

NTM lung disease isn’t rare anymore. Over the past few decades, researchers have tracked a steady increase in infections across the U.S., especially among people over 65 and those with structural lung issues like bronchiectasis or COPD. According to the Centers for Disease Control and Prevention, cases are growing by 8% annually. Currently there are estimated to be more than 200,000 cases in the U.S. alone.

Certain regions are being hit harder than others. States like Florida, Hawaii, California, and Texas report disproportionately high rates, with urban hubs like Chicago, Atlanta, Los Angeles, and New York City also seeing spikes. The combination of humid climates, aging populations, and exposure to aerosolized water from showers, hot tubs, or soil seems to provide the perfect conditions for the bacteria to thrive.

Still, it’s not limited to one geographic area. Wherever people are inhaling air from contaminated environments—and especially where structural lung conditions are common—NTM is a growing risk.

One of the most frustrating aspects of NTM is how easy it is to mistake it for something else. People often develop a persistent cough, fatigue, night sweats, or shortness of breath—symptoms that could point to any number of respiratory conditions. It’s not unusual for patients to be told they have bronchitis or asthma, and to be treated accordingly.

But when weeks turn into months, and standard treatments don’t work, it’s time to look deeper.

Diagnosis requires a chest CT scan and sputum cultures, but even then, identifying the right strain and choosing the right treatment takes time. The standard course involves multiple antibiotics taken for over a year, and in many cases, patients can be reinfected with another strain later on.

Behind the data are stories—some hopeful, some heartbreaking.

Diane, a retired teacher in Houston, spent more than two years bouncing between physicians. “I had a chronic cough I just couldn’t shake,” she says. “They thought it was allergies or maybe long COVID.” After finally seeing a pulmonologist who tested for NTM, she got her diagnosis. “I was relieved, but scared. I had never even heard of it.”

In Miami, Michael, 67, had a similar experience. “They told me it was COPD, and I believed them. But my energy kept getting worse.” It wasn’t until a specialist ordered a specific culture that the real cause came to light. “By then, my lungs were already in bad shape.”

These aren’t rare anecdotes—they’re reflective of a larger issue: too many patients are slipping through the cracks because NTM isn’t top of mind for most clinicians.

(*Stories are drawn from patient accounts shared with NTMir’s national support community. Names have been changed for privacy.*)

Every year, August 4 marks World NTM Day, an international effort to raise awareness about this under-recognized illness. The day offers an opportunity to elevate patient voices, educate health professionals, and encourage policy solutions to improve care.

This year, advocates are emphasizing five urgent needs:
1. Faster diagnosis.
2. More research for treatments.
3. Public awareness.
4. Research for ways to reduce exposure.
5. Support for patients.

The call to action is simple: If you’ve had a lingering cough or recurring respiratory symptoms, and especially if you already have a lung condition, ask your doctor whether NTM testing is appropriate.

NTM lung disease isn’t going away. But we do have reasons to be hopeful. New diagnostic tools are in development. Clinical trials are underway for more tolerable and effective medications. And groups like NTMir are building a stronger national patient registry to support research and care coordination.

What we don’t have—yet—is widespread awareness.

That’s where you come in. Whether you’re a patient, caregiver, physician, journalist, or policymaker, you can help shine a light on this overlooked disease. Share a story. Ask questions. Start the conversation.

Because when it comes to NTM, knowledge isn’t just power—it’s a lifeline.

To learn more about nontuberculous mycobacterial lung disease, and to get involved in World NTM Day on August 4, visit www.WorldNTMDay.org.

(NewsUSA) - For many, breathing is something we take for granted, 23,040 breaths a day without a second thought. But for those impacted by lung cancer, every breath matters.

On August 1, World Lung Cancer Day highlights the importance of lung cancer awareness, the urgency of research, and the power of personal stories, like Jeff Stibelman's.

From Stage 4 Diagnosis to a Full Life

Jeff never expected a persistent cough to turn into something serious. But in early 2021, after a scan revealed advanced-stage lung cancer, his life changed in an instant. The cancer had spread to his bones, ribs, clavicle, and brain, initially considered inoperable.

Jeff refused to give up. He educated himself and pursued biomarker testing. While every cancer journey is different, research made more options available to him, and that made a difference.

“I want my story to focus on the disease and the cure. It is because others before me advocated and made their needs heard that biomarker testing was discovered and, in turn, new highly effective drugs were developed. Getting more involved in research and doing my own research has become my purpose.”

Research That Breathes Life Into the Future

Behind stories like Jeff’s are the scientists pushing boundaries in lung cancer treatment. Dr. Zhen Zeng of Johns Hopkins University School of Medicine was recently awarded a prestigious Early Career Researcher Grant of $200,000 through LCFA.

Dr. Zeng’s work uses cutting-edge bioinformatics to identify tumor-reactive T cells, a breakthrough that could lead to more personalized and effective immunotherapy for patients.

“This grant gives me the resources to move faster,” says Dr. Zeng. “And that means earlier detection, better treatment options, and more lives saved.”

The impact of early detection is staggering: catching lung cancer at Stage I could improve five-year survival rates by more than 50%.

Every Post, Every Dollar, Every Breath Counts

On World Lung Cancer Day, LCFA encourages everyone to join the conversation. Through social media spotlights on survivors, updates from the lab, and stories from patients and doctors, the day reminds us that we all have lungs and a reason to care.

“Research is vital,” says LCFA Co-Founder Kim Norris. “Behind every story of hope, every extra moment, every second chance is research. But research doesn’t happen without support. It takes all of us, donors, advocates, and communities, working together to fuel the breakthroughs that help these stories continue. If you want to make a difference, please donate today, because every dollar moves research forward.”

How You Can Help

Donate: Supports lifesaving research.

https://secure.lcfamerica.org/forms/wlcd25

Share: Use your voice on social media to raise awareness.

Learn: Visit LCFAmerica.org to hear more stories and explore how research makes a difference.

Hashtags: #WorldLungCancerDay #LCFAmerica #LivingWithLungCancer #WLCD2025

Join the movement this World Lung Cancer Day. Because hope is real.

About LCFA: Lung Cancer Foundation of America enhances lung cancer survival rates by funding transformative science, elevating public awareness, and providing hope, information, and access to contemporary treatment options. Learn more at LCFAmerica.org.

(NewsUSA) - A medida que volvemos a hacer viajes, cocinar en el patio y pasar tiempo con los amigos y familiares este verano, el COVID-19 sigue siendo algo a lo que debemos prestar atención. Aunque el virus ya no ocupe los titulares, no ha desaparecido. De hecho, en cada uno de los últimos cuatro años, los casos de COVID-19 han aumentado en julio y agosto (en inglés).

¿Por qué sucede esto? El calor del verano suele invitar a las reuniones en espacios interiores y eventos en lugares con aire acondicionado, más viajes y más tiempo cerca de otras personas. Estas son algunas de las razones por las que el virus tiene más oportunidades de propagarse.

Aunque un caso leve de COVID-19 puede sentirse como un resfriado fuerte para algunas personas, en muchas otras puede causar problemas de salud graves, hospitalización o incluso la muerte. Los médicos afirman que casi 3 de cada 4 adultos en los Estados Unidos están con riesgo de enfermarse gravemente a causa del COVID-19. Esto incluye a personas con afecciones de salud comunes como enfermedades cardíacas, diabetes, cáncer, asma y otros problemas pulmonares. Incluso los adultos mayores de 50 años tienen más probabilidades de enfermarse de gravedad suficiente como para necesitar atención médica.

Las vacunas siguen siendo una defensa fuerte contra el COVID-19, pero puede que no protejan completamente a todas las personas, especialmente a quienes tienen otras afecciones de salud. Y esté alguien vacunado o no, es importante estar preparado y saber que existen tratamientos antivirales que pueden ayudar.

¿Qué son los antivirales?

Los medicamentos antivirales pueden ayudar a tu cuerpo a combatir el virus. Pueden evitar que los síntomas empeoren y prevenir una enfermedad más grave, reduciendo así la posibilidad de ser hospitalizado o morir por el COVID-19. Funcionan mejor si se toman dentro de los cinco días después de que comienzan los primeros síntomas. Por eso, actuar con rapidez es muy importante.

Muchas personas que podrían beneficiarse del tratamiento no saben que lo pueden recibir o no saben cómo encontrarlo rápidamente. Esto puede causar demoras, lo que hace que el medicamento sea menos eficaz.

“Algunas personas piensan que si ya se vacunaron o se sienten saludables, no necesitan tratamiento”, dijo Karyne Jones, presidenta y directora ejecutiva de NCBA, Inc. y convocante de CVEEP. “Pero eso no siempre es cierto. El COVID-19 aún puede causar enfermedad grave en muchas personas. Saber cuándo tomar antivirales y cómo obtenerlos puede ayudar a salvar vidas”.

Lo que puedes hacer ahora

Si te encuentras en el grupo de mayor riesgo de presentar complicaciones a causa del COVID-19, aquí hay algunos pasos que puedes dar para mantenerte seguro:

Conoce tu riesgo de enfermarte gravemente: Si tienes 50 años o más, o si tienes asma, cáncer, diabetes, una enfermedad cardíaca u otra afección de salud, es posible que tengas mayor riesgo de presentar una enfermedad grave por el COVID-19.

Habla con tu proveedor de atención médica: Pregunta si te convendría un tratamiento antiviral y dónde conseguirlo.

No esperes si comienzas a sentirte mal: Los antivirales funcionan mejor cuando se toman temprano, especialmente dentro de los primeros días después de que aparecen los síntomas.

El COVID-19 aún está presente, pero contamos con las herramientas para combatirlo. Estar preparado, mantenerse alerta y actuar con rapidez son las mejores formas de proteger tu salud y disfrutar del verano.

Para obtener más información, visita https://cveep.org/es/.

(NewsUSA) - As we get back to summer travel, cookouts, and time with friends and family, COVID-19 is still something to watch out for. While the virus may not be making big headlines, it hasn’t gone away. In fact, in each of the last four years, COVID-19 rates have gone up in July and August.

Why does this happen? The summer heat often means more indoor get-togethers and events in air-conditioned spaces, more travel, and more time spent around other people. These are just a few of the things that give the virus more chances to spread.

While a mild case of COVID-19 may feel like a bad cold for some, it can lead to serious health issues, hospitalization, or even death for many others. Doctors say nearly 3 out of 4 U.S. adults are more likely to get very sick from COVID-19. This includes people with common health conditions like heart disease, diabetes, cancer, asthma and other lung problems. Even adults over age 50 have a greater chance of getting sick enough to need medical care.

Vaccines are still a strong defense against COVID-19. But they may not fully protect everyone, especially those with other health issues. And whether someone’s vaccinated or not, it’s important to be prepared and know that there are antiviral treatments that can help.

What Are Antivirals?

Antiviral medicines can help your body fight off the virus. They can help stop symptoms from getting worse and prevent more serious illness, lowering the chance of going to the hospital or dying from COVID-19. They work best if you take them within five days after the first symptoms start. So, acting fast is very important.

Many people who could benefit from treatment don’t know they can get it or don’t know how to find it quickly. This can cause delays, which makes the medicine less helpful.

“Some people think that if they got the vaccine or feel healthy, they don’t need treatment,” said Karyne Jones, President and CEO of NCBA, Inc. and co-convener of CVEEP. “But that’s not always true. COVID-19 can still cause serious illness for many people. Knowing when to take antivirals, and how to get them, can help save lives.”

What You Can Do Now

If you are more likely to have problems from COVID-19, here are a few steps you can take to stay safe:

Know your chance of getting very sick: If you’re age 50 or older—or have asthma, cancer, diabetes, heart disease, or another health issue—you may be more likely to get very ill from COVID-19.

Talk to your healthcare provider: Ask if you might be someone who would benefit from an antiviral treatment and where to get it.
Don’t wait if you start to feel sick: Antivirals work best when taken early, especially within a few days of symptoms.

COVID-19 is still around, but we have tools to fight it. Being ready, staying alert, and acting quickly are the best ways to protect your health and enjoy your summer.

To learn more, visit cveep.org.

(Jill Purcell, Head of Dental and Vision Product and Network Management, Guardian and Shawn Patrick, Director of Strategic Growth, Kelsey National) - Maintaining good oral health is a crucial component of your overall well-being at any age, yet it becomes particularly important as we get older. Oral health is closely tied to not just our physical wellness but also our mental and financial well-being.

Unfortunately, far too many older Americans aren’t getting the dental care they need. In fact, one in four U.S. adults aged 65 and older have not had dental care in more than two years. With some Medicare plans scaling back dental benefits, now is the time to act.

The well-being connection

Oral health can have a lasting impact on your broader physical wellness. Without proper care, harmful bacteria can build up around teeth and cause gum disease or even spread to other parts of the body. Dry mouth, which can be caused by some medications as well as by CPAP use, can increase the risk of cavities and gum disease as well. Health conditions linked to poor oral health also include diabetes, kidney disease, dementia, pneumonia, and liver disease, among others.

This connection is particularly important for seniors to take into consideration. According to Guardian’s 2025 Mind, Body, and Wallet® report, 97% of Baby Boomers say that physical health plays an essential role in their well-being. Yet the impacts of oral health extend even further.

Guardian research has also found that poor oral health correlates with low self-esteem, anxiety, and depression. There’s a tie to financial wellness too, with the same study showing that adults over age 55 who do not receive annual dental exams and cleanings have higher claim costs compared to those who do.  

Despite its importance, many older Americans aren’t getting the care they need to support good oral health. According to the National Association of Dental Plans, approximately 31 million Americans ages 55 and older remain without dental coverage.

 The benefits of an individual dental plan

To help meet the needs of retirees and others who don’t have access to dental insurance through an employer, some carriers offer dental plans directly to consumers.

This is an option that provides a lot of benefits for seniors. For instance:

• You can assess a wide variety of plans at all different price points, including on third-party websites that make it easy to compare options.
• By selecting a carrier with a large provider network, you can find care where it is convenient for you. You may also be able to save on care costs with discounts that network dentists may provide in partnership with a carrier.
• With carriers that offer a self-service online platform, you can access information such as benefits details, claims history, network dentists near you, and ID cards, plus live support.
• Some carriers are even providing ongoing education about oral health and dental benefits, along with well-being support.

Now all that’s left is selecting the right plan.

What to look for in an individual dental plan

No two individuals are going to have the same exact oral care needs, regardless of age. Still, by keeping a few factors in mind, you can select the dental plan that will be the best fit for you.

For starters, finding a plan that covers preventive, basic, and major dental care is key. Also consider any other services beyond regular cleanings and x-rays you may want to use to be sure your plan covers them. Plus, if you have an immediate dental need, be on the lookout for waiting periods, which require that you be enrolled in the plan for a minimum number of months before a more expensive procedure may be covered.

Getting started

Maintaining good oral health as a senior has benefits that extend far beyond the teeth and mouth.

By finding the dental plan that’s right for you, you’re on your way to enhancing your oral health and overall well-being. Get started today.

(NewsUSA) - A once-a-day pill called blarcamesine may slow memory loss and preserve independence—without the scary side effects or burdens of current treatments.

If you love someone with Alzheimer’s, you know how quietly devastating the disease can be. One day it’s a forgotten name. A year later, it’s forgotten faces, forgotten routines. For many, even the latest treatments feel out of reach: risky, invasive, or simply too late.

But now, a new study offers something rare in Alzheimer's, a reason for hope. A once-daily pill called blarcamesine (pronounced blar-CAM-uh-seen) may actually slow the disease’s grip. And it does so safely, without the brain swelling and bleeding linked to some newer drugs.

The data, presented this spring at an international Alzheimer’s conference, showed that people who started taking blarcamesine early and stayed on it continuously had better memory, clearer thinking, and greater ability to handle everyday tasks—even after nearly four years.

For families trying to hang on to time and dignity, that’s no small thing.

As Dr. Timo Grimmer, a lead scientist on the study, put it: “Diagnosing and treating people earlier and consistently may lead to greater clinical benefit.”

Blarcamesine isn’t an infusion. There’s no monthly IV. No MRI scans. No trips to specialty hospitals. Just one pill a day.

That simplicity matters. Many Alzheimer’s treatments today require hospital visits, specialized imaging, and high-risk monitoring for side effects. These hurdles often make access harder for families without nearby clinics or flexible jobs.

"Oral medications like blarcamesine are more convenient for many patients as they can take medication at home without requiring regular clinic visits or infusion appointments," says Amy Reichelt, Ph.D., a neuroscientist and drug development expert. "Monoclonal antibodies require regular infusion center visits (typically every 2–4 weeks), which creates significant logistical burdens for patients and caregivers."

Still, there are trade-offs. “Adherence challenges exist with oral Alzheimer's medications as patients can forget to take their medications,” Reichelt adds. “However, the convenience of home administration is valuable for Alzheimer's patients who may struggle with transportation and clinic visits as their condition progresses.”

Let’s put the science in plain terms.

In the study, people who began taking blarcamesine right away had stronger thinking skills than those who started a year later. Their memory declined more slowly, and they were better able to handle basic tasks like dressing or preparing food.

And while the numbers may sound small—three or four points better on a memory scale—experts say that’s enough to change daily life. It might mean still knowing your grandchildren’s names. Still walking safely. Still living independently.

The safety data is especially striking. "A recent Phase 2b/3 clinical study with blarcamesine showed that there was no evidence of neurological tissue damage such as hemorrhage or Amyloid-related imaging abnormalities (ARIA), which have been observed with lecanemab and donanemab," Reichelt explains. Those antibody drugs require regular MRI scans to monitor ARIA, a side effect that can force treatment to stop.

"The risk of ARIA requires frequent patient monitoring by MRI and can lead to treatment discontinuation," she says. "However, the frequent monitoring with MRI might catch increasing disease progression or other pathologies."

While safety and simplicity are headline features, the economics of a pill like blarcamesine could be just as powerful.

“Key economic factors include reduced monitoring costs, as frequent MRI scans are costly,” Reichelt notes. “And some individuals are incompatible with MRIs due to metal implants or claustrophobia.”

IV infusions come with additional costs—nursing time, facility fees, medication prep, and more. “Moreover, caregiver time, transportation, and lost productivity for caregivers dealing with regular infusion appointments can be substantial, particularly as patients become less mobile,” Reichelt adds.

“Oral medications typically have broader insurance coverage and accessibility, especially in rural or underserved areas where access to infusion centers may be limited,” she says. “The potential cost savings of an oral medication without MRI monitoring is likely significant for both insurance payers, and patient experience and treatment adherence may also be improved.”

Blarcamesine is still under review by health authorities in Europe. It’s not yet approved for general use in the U.S. But the signs are encouraging, and the pressure is growing.

There are nearly 7 million Americans living with Alzheimer’s. Many current treatments are too complex, too risky, or simply too late. Families deserve better options. Safer options. Smarter options.

That’s what makes blarcamesine so compelling. It’s not just another high-tech moonshot. It’s a practical, patient-friendly approach that could help more people, sooner.

(Madison Roberts, Contributor) - It might sound like science fiction: a molecule already inside your body holds the potential to slow the aging process, sharpen the mind, and energize the body. Yet in the ever-evolving frontier of longevity research, NAD⁺ a coenzyme found in every living cell, is emerging as one of the most talked-about elements in the science of aging.

At the intersection of this conversation is Eden, a fast-growing health platform that’s betting big on the future of metabolic wellness. Their latest offering? Facilitated access to NAD⁺ injection programs via online consultations with licensed medical providers.

It’s not a miracle cure, far from it. But Eden is positioning itself as a leader in democratizing access to emerging longevity therapies. And that, in itself, is a story worth watching.

Nicotinamide adenine dinucleotide, or NAD⁺, may not be a household name yet. But within the cells of your body, it plays a starring role in essential functions: converting food into energy, supporting mitochondrial health, repairing DNA, and regulating cellular stress responses.

The problem? NAD⁺ levels decline sharply with age.

This natural drop-off has been linked in early studies to fatigue, cognitive sluggishness, and decreased physical resilience. Which is why researchers have spent the last decade looking into whether restoring NAD⁺ levels often using precursors like NMN or NR could enhance quality of life as we age.

In a 2022 human clinical trial published in NPJ Aging, older men supplemented with NMN showed measurable improvements in muscle strength and gait speed over 12 weeks. Other animal studies suggest NAD⁺ precursors might improve memory, slow vascular aging, and even boost circadian rhythm in aging mice​.

These findings are far from conclusive, but they’ve sparked a wave of interest from both scientists and consumers eager to better understand the biology of aging.

Eden doesn’t develop treatments, prescribe medications, or claim to reverse aging. What it does is enable people to consult with licensed medical providers who are fluent in emerging metabolic health strategies, including NAD⁺ protocols. It’s a modern, tech-enabled version of personalized wellness.

“People want more than the status quo, they want smarter, proactive conversations about their health,” said Josh Khan, Eden’s President and Co-Founder. “That’s what we’re here to support: evidence-based access, not hype.”

Starting at $189 per month, Eden’s NAD⁺ program connects users with licensed clinicians for one-on-one consultations. If NAD⁺ therapy is deemed appropriate, patients receive a personalized plan, and prescriptions are filled by licensed compounding pharmacies.

For Adam McBride, Eden’s CEO and Co-Founder, the NAD⁺ program reflects a broader philosophy.

“Our approach isn’t about chasing fads,” McBride told me. “It’s about grounding care in real science, giving people access to professionals who can help them navigate what’s possible, what’s proven, and what still needs more data.”

Earlier this month, Eden made a headline-grabbing hire that signaled just how serious it is about longevity. Dr. Halland Chen, MD, a double board-certified physician with deep roots in regenerative and functional medicine joined the company as Chief Medical Innovation Officer.

Dr. Halland is no stranger to the spotlight. Known in elite wellness circles as “The Longevity Doctor,” his work spans regenerative medicine, IV NAD⁺ infusions, and personalized anti-aging protocols.

“I’m really excited to be working with Eden to rethink how people approach metabolic health,” Dr. Halland said. “There’s enormous potential in combining regenerative medicine, functional strategies, and personalized data. The future of wellness isn’t one-size-fits-all, it’s precision-guided.”

Dr. Halland’s appointment brings Eden closer to the growing field of personalized medicine, where genetics, lifestyle, and biology are combined to develop tailored health plans. His clinical experience, paired with Eden’s digital infrastructure, offers a compelling model for what aging care could look like in the next decade.

So what can NAD⁺ actually do? The scientific community is cautiously optimistic.

In recent years, multiple studies have hinted at a wide range of potential benefits, from enhanced mitochondrial function and muscle endurance to improved cognition and sleep quality. In one of the most cited animal studies, aged mice given NMN showed increased capillary density and endurance levels comparable to younger mice, suggesting a reversal of age-related vascular decline​.

Human trials, though still limited, are beginning to echo some of these results. A placebo-controlled study in postmenopausal women found that NR (a NAD⁺ precursor) increased NAD⁺ levels and showed signs of reduced liver fat, a promising biomarker for metabolic improvement​.

Yet experts are quick to point out that NAD⁺ therapy remains investigational. Much of the most exciting research is still in the preclinical or early human trial phase. While the potential is there, the proof is still being built.

“We’re not promising miracles,” said Dr. Halland. “But we are helping people engage with the latest science in a responsible, informed way.”

The promise of NAD⁺ isn’t about living forever. It’s about living better.

“What people are really looking for isn’t more years, it’s better years,” McBride said. “If NAD⁺ turns out to be one tool that helps people feel sharper, move more easily, or recover faster as they age, that’s meaningful.”

For Eden, the NAD⁺ program is part of a larger trend: a shift away from reactive medicine and toward proactive wellness. The platform now supports provider-guided care for whole body health, all tailored to the individual.

“Longevity isn’t about avoiding death,” added Dr. Halland. “It’s about maximizing life physically, mentally, emotionally. NAD⁺ is one part of that story. And we’re just getting started.”

Aging isn’t what it used to be. And neither is healthcare.

With its NAD⁺ injection program, Eden isn’t offering a silver bullet, but it is offering something that’s become increasingly rare in modern medicine: access to timely, evolving science delivered through a human conversation.

Whether NAD⁺ ultimately becomes a foundational tool in the longevity toolkit remains to be seen. But for now, Eden’s model, equal parts access, innovation, and restraint, may be one of the most compelling developments in the wellness world today.

(NewsUSA) - Spring is the season of fresh starts and new beginnings. As it draws to a close and we head into summer, we are taking a look at how the millions of Americans living with diabetes can use the change in season to kickstart better habits or try something new.

To point us in the right direction, we spoke to Mary Bacchus about the demands of managing diabetes. Alongside the condition, Mary has to balance a full time job with a busy family life, featuring a partner who serves in the military, an active 10-year old son, and a mother who she cares for.

Mary is a strong believer in advocating for yourself and taking control of your own life. She says it is so important to feel confident and be able to challenge recommendations and ask difficult questions, especially when it comes to your health and wellbeing. She says “Diabetes impacts you as an individual the most, and Spring is the perfect time to make a change. Start taking control of your life!”

20 years ago Mary’s life changed forever when she was diagnosed with type one diabetes at age 18. Managing her diabetes as a teenager whilst juggling college and work was a huge challenge, especially when it came to the complex payment and insurance landscape. Things only got more complicated once she entered motherhood.

“There is so much to think about all of the time and it’s impossible to get things right every step of the way. But that’s okay. Some days are more frustrating than others but I find that it helps to hold onto something positive – even if it is small – to make things feel a little easier. My most important learnings are about the power and importance of community, listening to those around you, and never being afraid to try something new,” Mary adds.

After lots of trial and error, Mary learnt to cope with the demands of life alongside taking care of her diabetes. She wouldn’t have been able to do this without gradually growing her support network, initially from her husband and son, into a dependable community both online and locally.  Another two pieces of the puzzle were her healthcare team and a groundbreaking technology – the Eversense continuous glucose monitoring (CGM) system.

CGMs have become a common technology for tracking glucose, which is crucial in diabetes management. However, the limitations of many available CGMs were making life difficult for Mary.

“I became more and more frustrated with the options available to me to manage my diabetes. I started using CGMs when my son was a toddler, and found it really difficult to stop my CGM from being knocked off when we would play. Every time it would come off, I’d either have to pay for a replacement and wait for it to arrive, or go back to manually testing my levels which was just another thing to think about.”

After trying several traditional CGMs, she discovered Eversense in 2020 and has never looked back. The implantable design of the Eversense CGM sensor simplified Mary’s diabetes care, placed fewer constraints on her daily life and gave her a dependable solution to manage her health.

Eversense’s tiny sensor rests comfortably under the skin, whilst the removable transmitter* is held firmly in place on the outside of the arm with a gentle, daily-use, double-sided silicon-based adhesive. If it is knocked off then it can simply be replaced without wasting a CGM.

“Being able to take my transmitter off and on without any cost or inconvenience is an irreplaceable benefit. Whilst we don’t play like we did when my son was younger, I’m able to keep up with my son at sporting events, concerts, and amusement parks without worrying if my CGM will keep up with me. As a mom, I get real joy from being able to spend quality time with my son without worrying about my CGM and it’s something I’m so grateful for every day.”

With each sensor lasting an entire year, Eversense 365 empowers people like Mary in their diabetes management, so they can live their best life, with fewer interruptions.

Mary offered some wisdom to other diabetes patients and said, “I encourage everyone in the diabetes community to revitalize their approach to diabetes monitoring this Spring! We are part of a unique community which should serve as a safe space to discuss our experiences and learn from each other.”

Why not join Mary and kickstart summer with a new approach to diabetes management. Get a fresh perspective on diabetes management at eversensecgm.com and bring a new sense of renewal to your year.

Mary Bacchus is an Eversense brand ambassador and this article was sponsored by Ascensia Diabetes Care

Please note for important safety information, see https://www.eversensediabetes.com/safety-info

* There is no glucose data generated when he transmitter is removed